Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Age-specific distributions of cytogenetic subgroups of acute myeloid leukemia: data analysis in a Chinese population.

Su L, Gao S, Li W, Tan Y, Yang L, Liu Z, Bai O, Yang Y, Yao C, Song Y, Wang G.

Acta Haematol. 2013;129(3):175-81. doi: 10.1159/000345250. Epub 2012 Dec 13.

PMID:
23257712
2.

[The study on relationship between age and cytogenetic subgroups in 640 patients with de novo acute myeloid leukemia].

Su L, Gao SJ, Li W, Tan YH, Yao C, Song YQ, Yang Y, Liu ZL, Bai O, Lin H, Yang L, Wang C, Cui JW, Wang GJ.

Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):133-7. Chinese.

PMID:
23611220
3.

IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia and associated with NPM1 mutations and FAB-M2 subtype.

Chao HY, Jia ZX, Chen T, Lu XZ, Cen L, Xiao R, Jiang NK, Ying JH, Zhou M, Zhang R.

Int J Lab Hematol. 2012 Oct;34(5):502-9. doi: 10.1111/j.1751-553X.2012.01422.x. Epub 2012 Apr 11.

PMID:
22494415
4.
5.

Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.

Bacher U, Kern W, Schnittger S, Hiddemann W, Haferlach T, Schoch C.

Haematologica. 2005 Nov;90(11):1502-10.

6.

High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.

Tang R, Hirsch P, Fava F, Lapusan S, Marzac C, Teyssandier I, Pardo J, Marie JP, Legrand O.

Blood. 2009 Oct 1;114(14):2993-3000. doi: 10.1182/blood-2009-05-223115. Epub 2009 Jul 30.

7.

Nucleophosmin mutation in Southeast Asian acute myeloid leukemia: eight novel variants, FLT3 coexistence and prognostic impact of NPM1/FLT3 mutations.

Boonthimat C, Thongnoppakhun W, Auewarakul CU.

Haematologica. 2008 Oct;93(10):1565-9. doi: 10.3324/haematol.12937. Epub 2008 Jul 18.

8.

Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China.

Cheng Y, Wang Y, Wang H, Chen Z, Lou J, Xu H, Wang H, Qian W, Meng H, Lin M, Jin J.

Leukemia. 2009 Oct;23(10):1801-6. doi: 10.1038/leu.2009.107. Epub 2009 May 28.

PMID:
19474801
9.

Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes.

Zaker F, Mohammadzadeh M, Mohammadi M.

Arch Iran Med. 2010 Jan;13(1):21-5.

10.

Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.

Ishikawa Y, Kiyoi H, Tsujimura A, Miyawaki S, Miyazaki Y, Kuriyama K, Tomonaga M, Naoe T.

Eur J Haematol. 2009 Aug;83(2):90-8. doi: 10.1111/j.1600-0609.2009.01261.x. Epub 2009 Mar 21.

PMID:
19309322
11.
12.

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.

Clin Cancer Res. 2005 Feb 15;11(4):1416-24. Erratum in: Clin Cancer Res. 2005 Aug 1;11(15):5659.

13.

FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.

Zhong L, Jia YQ, Meng WT, Ni X.

Arch Pathol Lab Med. 2012 Jan;136(1):84-9. doi: 10.5858/arpa.2010-0700-OA.

PMID:
22208491
14.

Prognostic factors in AML in relation to (ab)normal karyotype.

Stone RM.

Best Pract Res Clin Haematol. 2009 Dec;22(4):523-8. doi: 10.1016/j.beha.2009.07.003. Review.

PMID:
19959103
15.

Comprehensive profile of cytogenetics in 2308 Chinese children and adults with de novo acute myeloid leukemia.

Li X, Li X, Xie W, Hu Y, Li J, Du W, Liu W, Li H, Chen X, Zhang L, Wang J, Huang S.

Blood Cells Mol Dis. 2012 Aug 15;49(2):107-13. doi: 10.1016/j.bcmd.2012.05.007. Epub 2012 Jun 9.

PMID:
22683308
16.

Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.

Hoffmann MH, Klausen TW, Boegsted M, Larsen SF, Schmitz A, Leinoe EB, Schmiegelow K, Hasle H, Bergmann OJ, Sorensen S, Nyegaard M, Dybkaer K, Johnsen HE.

Cytometry B Clin Cytom. 2012 May;82(3):123-31. doi: 10.1002/cyto.b.20633. Epub 2012 Feb 10.

17.

NPM1, FLT3, and c-KIT mutations in pediatric acute myeloid leukemia in Russian population.

Yatsenko Y, Kalennik O, Maschan M, Kalinina I, Maschan A, Nasedkina T.

J Pediatr Hematol Oncol. 2013 Apr;35(3):e100-8. doi: 10.1097/MPH.0b013e318286d261.

PMID:
23511494
18.

Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.

Schwartz S, Heinecke A, Zimmermann M, Creutzig U, Schoch C, Harbott J, Fonatsch C, Löffler H, Büchner T, Ludwig WD, Thiel E.

Leuk Lymphoma. 1999 Jun;34(1-2):85-94.

PMID:
10350335
19.

FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.

Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.

Ann Hematol. 2012 Nov;91(11):1703-12. doi: 10.1007/s00277-012-1509-z. Epub 2012 Jun 26.

PMID:
22733614
20.

Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.

Rossi G, Pelizzari AM, Bellotti D, Tonelli M, Barlati S.

Leukemia. 2000 Apr;14(4):636-41.

PMID:
10764149

Supplemental Content

Support Center